1. Home
  2. ELDN vs LMNR Comparison

ELDN vs LMNR Comparison

Compare ELDN & LMNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

HOLD

Current Price

$1.97

Market Cap

219.4M

Sector

Health Care

ML Signal

HOLD

Logo Limoneira Co

LMNR

Limoneira Co

SELL

Current Price

$10.02

Market Cap

218.5M

ML Signal

SELL

Company Overview

Basic Information
Metric
ELDN
LMNR
Founded
2004
1893
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
219.4M
218.5M
IPO Year
2014
2005

Fundamental Metrics

Financial Performance
Metric
ELDN
LMNR
Price
$1.97
$10.02
Analyst Decision
Strong Buy
Buy
Analyst Count
6
3
Target Price
$9.00
★ $19.63
AVG Volume (30 Days)
★ 918.4K
113.4K
Earning Date
11-12-2026
12-22-2026
Dividend Yield
N/A
★ 0.76%
EPS Growth
★ 30.67
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $159,723,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$17.92
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.35
$9.77
52 Week High
$4.49
$15.43

Technical Indicators

Market Signals
Indicator
ELDN
LMNR
Relative Strength Index (RSI) 35.64 34.47
Support Level N/A N/A
Resistance Level $3.14 $13.71
Average True Range (ATR) 0.27 0.42
MACD -0.07 -0.00
Stochastic Oscillator 3.83 12.54

Price Performance

Historical Comparison
ELDN
LMNR

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

About LMNR Limoneira Co

Limoneira Co is predominantly an agribusiness company. Its current operations consist of fruit production and marketing, rental operations, real estate, and capital investment activities. The company has three business divisions; agribusiness, rental operations, and real estate development. The agribusiness division which accounts for a majority of the firm's revenue represents its core operations of farming, harvesting, lemon packing, and lemon sales operations. The company's reportable operating segments are fresh lemons, lemon packing, avocados, and other agribusiness, which predominantly includes oranges, specialty citrus, other crops, and farm management services. A majority of its revenue is derived from the Fresh Lemons segment.

Share on Social Networks: